Form EFFECT Eliem Therapeutics, Inc.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | July 23, 2024 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Claims Deadline Extended for National Rexulti Class Action Settlement
- NEXCOM Unveils DTA 1600 to Solve SMB Network Constraints with Enterprise-grade Security
- OKI Signs Supply Contract with Mitsubishi Heavy Industries for Towed Passive Sonar for Australia’s New General-Purpose Frigates
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
